New combo therapy aims to cut transfusions and boost brain health in premature infants

This study tests whether giving preterm babies (born before 32 weeks) a drug called darbepoetin plus a slow-release intravenous iron can reduce the need for blood transfusions, keep their iron levels healthy, and improve their brain development. About 120 infants will be enrolled and compared to those receiving standard oral iron. The goal is to find a safer, more effective way to support these fragile newborns.